IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
EMBO molecular medicine, 2016-09, Vol.8 (9), p.1099-1112 [Peer Reviewed Journal]2016 The Authors. Published under the terms of the CC BY 4.0 license ;2016 The Authors. Published under the terms of the CC BY 4.0 license. ;COPYRIGHT 2016 John Wiley & Sons, Inc. ;2016. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201606413 ;PMID: 27520969
Full text available